AM-938

From WikiMD's WELLNESSPEDIA

AM-938_Structure.svg

Synthetic cannabinoid

AM-938 is a synthetic cannabinoid that acts as a potent and selective agonist for the cannabinoid receptors. It is structurally related to other synthetic cannabinoids such as AM-2201 and JWH-018.

Chemical Structure[edit]

AM-938 belongs to the class of indole-based synthetic cannabinoids. The chemical structure of AM-938 includes a core indole structure with various substituents that enhance its affinity and selectivity for cannabinoid receptors.

Pharmacology[edit]

AM-938 acts primarily on the CB1 and CB2 receptors, which are part of the endocannabinoid system. These receptors are involved in a variety of physiological processes including pain, appetite, mood, and memory.

Legal Status[edit]

The legal status of AM-938 varies by country. In some jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of medical use. In others, it may be legal or regulated under different frameworks.

Research and Applications[edit]

AM-938 is primarily used in scientific research to study the endocannabinoid system and the effects of synthetic cannabinoids. It has been used in various preclinical studies to understand its pharmacological properties and potential therapeutic applications.

Safety and Toxicity[edit]

The safety profile of AM-938 is not well-documented, and its use is generally limited to controlled laboratory settings. Potential adverse effects may include tachycardia, anxiety, and hallucinations, similar to other synthetic cannabinoids.

See Also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.